Know Cancer

or
forgot password
  • cancer clinical trials in jackson, MS

  • S0014 Combination Chemotherapy Plus Rituximab and Radiation Therapy in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Lymphoma
    Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Sarcoma
    S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
    Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Leukemia
    Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Mississippi Urology Clinic, P.A.
    Jackson, Mississippi 39202
    Bladder Cancer
    Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherapy
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Fever, Sweats, and Hot Flashes, Neutropenia, Unspecified Childhood Solid Tumor, Protocol Specific
    Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Melanoma (Skin), Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific
    Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Leukemia
    Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Leukemia, Myelodysplastic Syndromes, Sarcoma
    Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Childhood Germ Cell Tumor, Drug/Agent Toxicity by Tissue/Organ, Extragonadal Germ Cell Tumor, Ovarian Cancer
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Breast Cancer
    Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Brain and Central Nervous System Tumors
    Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Sarcoma
    STI571 in Treating Patients With Recurrent Leukemia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Leukemia
    Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Brain and Central Nervous System Tumors
    Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Herpes Simplex
    Paclitaxel in Treating Patients With Ovarian Stromal Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Ovarian Cancer
    Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Leukemia
    Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Endometrial Cancer
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    Jackson Oncology Associates, PLLC
    Jackson, Mississippi 39202
    Colorectal Cancer
    Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Prostate Cancer
    Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Veterans Affairs Medical Center - Jackson
    Prostate Cancer
    S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Multiple Myeloma
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Breast Cancer
    S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    University of Mississippi Cancer Clinic

    Trial Locations
    University of Mississippi Cancer Clinic
    St. Dominic Cancer Center
    Endometrial Cancer
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Brain Tumor, Central Nervous System Tumor
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Kidney Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Leukemia
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Saint Dominic-Jackson Memorial Hospital
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Veterans Affairs Medical Center - Jackson

    Trial Locations
    Veterans Affairs Medical Center - Jackson
    University of Mississippi Cancer Clinic
    Metastatic Cancer, Prostate Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Dominic-Jackson Memorial Hospital
    Jackson, Mississippi 39216
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Head and Neck Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    University of Mississippi Medical Center

    Trial Locations
    University of Mississippi Medical Center
    Jackson Oncology Associates PLLC
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Veterans Affairs Medical Center
    Jackson, Mississippi 39216
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    University of Mississippi Cancer Clinic
    Jackson, Mississippi 39216-4505
    Kidney Cancer
    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
    University of Mississippi Medical Center
    Jackson, Mississippi 39216-4505
    Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
    Research Center In
    Jackson, Mississippi
    Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer